Feasibility of IMP-3 as an Invasiveness Marker for Acral Lentiginous Melanoma

참고문헌 (10)

1. Chang JW, "Malignant melanoma in Taiwan: a prognostic study of 181 cases", Melanoma Res, 14, pp.537~541 (2004)[DOI]
2. Bradford PT, "Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005", Arch Dermatol, 145, pp.427~434 (2009)
3. Ito T, "The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan", Melanoma Res, 22, pp.38~44 (2012)[DOI]
4. Phan A, "Acral lentiginous melanoma: a clinicoprognostic study of 126 cases", Br J Dermatol, 155, pp.561~569 (2006)[DOI]
5. Krementz ET, "Acral lentiginous melanoma. A clinicopathologic entity", Ann Surg, 195, pp.632~645 (1982)[DOI]
6. Slingluff CL Jr, "Acral melanoma: a review of 185 patients with identification of prognostic variables", J Surg Oncol, 45, pp.91~98 (1990)[DOI]
7. Pryor JG, "IMP-3 is a novel progression marker in malignant melanoma", Mod Pathol, 21, pp.431~437 (2008)[DOI]
8. Yu L, "IMP-3 expression in melanocytic lesions", J Cutan Pathol, 37, pp.316~322 (2010)[DOI]
9. Sheen YS, "Insulin-like growth factor II mRNA-binding protein 3 expression correlates with poor prognosis in acral lentiginous melanoma", PLoS One, 11, pp.e0147431~ (2016)[DOI]
10. Sheen YS, "IMP-3 promotes migration and invasion of melanoma cells by modulating the expression of HMGA2 and predicts poor prognosis in melanoma", J Invest Dermatol, 135, pp.1065~1073 (2015)[DOI]

관련 논문AI추천